Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium

Experimental Physiology

Volumn 88, Issue 2, 2003, Pages 209-219

  Rojas, Susana ^a   Rojas, Romina ^a   Lamperti, Liliana ^a   Casanello, Paola ^a   Sobrevia, Luis ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CALPHOSTIN C; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLIC GMP DEPENDENT PROTEIN KINASE INHIBITOR; DNA; GLUCOSE; GUANOSINE PHOSPHATE; KT 5720; KT 5823; LEVO GLUCOSE; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NUCLEOSIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SUPEROXIDE DISMUTASE; THYMIDINE;

CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CELL VOLUME; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; DNA CONTENT; DNA SYNTHESIS; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; GROWTH CURVE; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INCUBATION TIME; PROTEIN CONTENT; REVIEW; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0037341668     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/eph8802515     Document Type: Review

References (50)

1. Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J & Ahmed A (2001). Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 159, 993-1008.
2. 2+-calmodulin-dependent protein kinase on neurite development in cultured rat hippocampal neurons. Int J Dev Neurosci 11, 357-368.
3. +/hCAT-2B, and lower activity of nitric oxide synthase in human umbilical vein endothelial cells. Circ Res 91, 127-134.
4. Cheng JJ, Wung BS, Chao YJ & Wang DL (2001). Sequential activation of protein kinase C (PKC)-alpha and PKC-epsilon contributes to sustained Raf/ERK1/2 activation in endothelial cells under mechanical strain. J Biol Chem 276, 31368-31375.
5. Crews CM & Eriksson RL (1992). Purification of a murine protein-tyrosine threonine kinase that phosphorylates and activates the ERK-1 gene product: relationship to the fission yeast vyr1 gene product. Proc Natl Acad Sci U S A 89, 8205-8209.
6. De Vriese AS, Verbeuren TJ, Van De Voorde J, Lameire NH & Vanhoutte PM (2000). Endothelial dysfunction in diabetes. Br J Pharmacol 130, 963-974.
7. Deisher TA, Sato TT, Pohlman TH & Harlan JM (1993). A protein kinase C agonist, selective for the beta I isozyme, induces E-selectin and VCAM-1 expression on HUVEC but does not translocate PKC. Biochem Biophys Res Commun 193, 1283-1290.
8. mapk and nitric oxide in human umbilical vein endothelium. Circ Res 92, 64-72.
9. Frodin M, Peraldi P & Van Obberghen E (1994). Cyclic AMP activates the mitogen-activated protein kinase cascade in PC12 cells. J Biol Chem 269, 6207-6214.
10. Genersch E, Hayess K, Neuenfeld Y & Haller H (2000). Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J Cell Sci 113, 4319-4330.
11. Grant MB, Tarnuzzer RW, Caballero S, Ozeck MJ, Davis MI, Spoerri PE, Feoktistov I, Biaggioni I, Shryock JC & Belardinelli L (1999). Adenosine receptor activation induces vascular endothelial growth factor in human retinal endothelial cells. Circ Res 85, 699-706.
12. Grider JR (1993). Interplay of VIP and nitric oxide in regulation of the descending relaxation phase of peristalsis. Am J Physiol 264, G334-340.
13. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M & Kikkawa R (1997). Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46, 847-853.
14. Harper JF (1984). Peritz' F test: BASIC program of a robust multiple comparison test for statistical analysis of all differences among group means. Comput Biol Med 14, 437-445.
15. Heller R, Polack T, Grabner R & Till U (1999). Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. Atherosclerosis 144, 49-57.
16. 2-terminal kinase and caspase-3. Circulation 101, 2618-2624.
17. Kim TY, Kim WI, Smith RE & Kay ED (2001). Role of p27(Kip1) in cAMP- and TGF-beta2-mediated antiproliferation in rabbit corneal endothelial cells. Invest Ophthalmol Vis Sci 42, 3142-3149.
18. Kobayashi E, Ando K, Nakano H, Iida T, Ohno H, Morimoto M & Tamaoki T (1989). Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo) 42, 1470-1474.
19. Kyriakis JM & Avruch J (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81, 807-869.
20. Lau YT & Ma WC (1996). Nitric oxide inhibits migration of cultured endothelial cells. Biochem Biophys Res Commun 221, 670-674.
21. Lazar DF, Wiese RJ, Brady MJ, Mastick CC, Waters SB, Yamauchi K, Pessin JE, Cuatrecasas P & Saltiel AR (1995). Mitogen-activated protein kinase kinase inhibition does not block the stimulation of glucose utilization by insulin. J Biol Chem 270, 20801-20807.
22. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W & Ullrich A (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
23. Misra HP (1989). Adrenochrome assay. In Handbook of Methods for Oxygen Radical Research, ed. Greenwald RA, pp. 237-241. CRC Press, Boca Raton.
24. Montecinos VP, Aguayo C, Flores C, Wyatt AW, Pearson JD, Mann GE & Sobrevia L (2000). Regulation of adenosine transport by D-glucose in human fetal endothelial cells: involvement of nitric oxide, protein kinase C and mitogen-activated protein kinase. J Physiol 529, 777-790.
25. Morigi M, Angioletti S, Imberti B, Donadelli R, Micheletti G, Figliuzzi M, Remuzzi A, Zoja C & Remuzzi G (1998). Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion. J Clin Invest 101, 1905-1915.
26. Pan M, Wasa M, Lind DS, Gertler J, Abbott W & Souba WW (1995). TNF-stimulated arginine transport by human vascular endothelium requires activation of protein kinase C. Ann Surg 221, 590-601.
27. Parenti A, Morbidelli L, Cui XL, Douglas JG, Hood JD, Granger HJ, Ledda F & Ziche M (1998). Nitric oxide is an upstream signal of vascular endothelial growth factor-induced extracellular signal-regulated kinase 1/2 activation in postcapillary endothelium. J Biol Chem 273, 4220-4226.
28. 2Y2 purinoceptors in human umbilical vein endothelial cells. Circ Res 90, 570-577.
29. Pedron T, Girard R & Chab R (2000). Down-modulation through protein kinase C-alpha of lipopolysaccharide-induced expression of membrane CD14 in mouse bone marrow granulocytes. Biochem Pharmacol 60, 1837-1843.
30. Radallah D, Nogaro M & Fournier B (1999). Protein kinase C stimulates PtdIns-4,5-P2-phospholipase C activity. Biochim Biophys Acta 1450, 242-253.
31. Rojas S, Aguayo C, Flores C & Sobrevia L (2000). Differential role of protein kinase C in D-glucose-induced inhibition of L-leucine and thymidine incorporation into macromolecules in human fetal endothelium. J Physiol 525.P, 17P.
32. Ross D & Joyner WL (1997). Resting distribution and stimulated translocation of protein kinase C isoforms alpha, epsilon and zeta in response to bradykinin and TNF in human endothelial cells. Endothelium 5, 321-332.
33. Schnackenberg CG & Wilcox CS (2001). The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 59, 1859-1864.
34. Sen RP, Delicado EG, Castro E & Miras-Portugal MT (1993). Effect of P2y agonist on adenosine transport in cultured chromaffin cells. J Neurochem 60, 613-619.
35. Shaul PW (2002). Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64, 749-774.
36. +, and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol 489, 183-192.
37. Sobrevia L, Jarvis SM & Yudilevich D (1994). Adenosine transport in cultured human umbilical vein endothelial cells is reduced in diabetes. Am J Physiol 267, C39-47.
38. +) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J Physiol 490, 775-781.
39. Soler C, Felipe A, Mata JF, Casado FJ, Celada A & Pastor-Anglada M (1998). Regulation of nucleoside transport by lipopolysaccharide, phorbol esters, and tumor necrosis factor-alpha in human B-lymphocytes. J Biol Chem 273, 26939-26945.
40. Spyridopoulos I, Luedemann C, Chen D, Kearney M, Chen D, Murohara T, Principe N, Isner JM & Losordo DW (2002). Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability. Arterioscler Thromb Vasc Biol 22, 901-906.
41. Vossler MR, Yao H, York RD, Pan MG, Rim CS & Stork PJ (1997). cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89, 73-82.
42. Wang J, Morita I, Onodera M & Murota SI (2002). Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide. J Cell Physiol 190, 238-250.
43. Wellner M, Maasch C, Kupprion C, Lindschau C, Luft FC & Haller H (1999). The proliferative effect of vascular endothelial growth factor requires protein kinase C-alpha and protein kinase C-zeta. Arterioscler Thromb Vasc Biol 19, 178-185.
44. Wilkinson SE, Parker PJ & Nixon JS (1993). Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C. Biochem J 294, 335-337.
45. Wu KY, Hong SJ, Lin CP, Lai YH & Wang HZ (2001). Endothelin-induced changes of secondary messengers in cultured corneal endothelial cells. J Ocul Pharmacol Ther 17, 351-361.
46. Wu LW, Mayo LD, Dunbar JD, Kessler KM, Baerwald MR, Jaffe EA, Wang D, Warren RS & Donner DB (2000). Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J Biol Chem 275, 5096-5103.
47. Young SW, Dickens M & Tavare JM (1994). Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters. FEBS Lett 338, 212-216.
48. Zanetti M, Zwacka R, Engelhardt J, Katusic Z & O'Brien T (2001). Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia. Arterioscler Thromb Vasc Biol 21, 195-200.
49. Zhang Z, Apse K, Pang J & Stanton RC (2000). High glucose inhibits glucose-6-phosphate dehydrogenase via cAMP in aortic endothelial cells. J Biol Chem 275, 40042-40047.
50. Ziemianin B, Olszanecki R, Uracz W, Marcinkiewicz E & Gryglewski RJ (1999). Thienopyridines: effects on cultured endothelial cells. J Physiol Pharmacol 50, 597-604.